Our study investigates delays in referral for penile cancer and their impact on patient outcomes. Even in high-income settings, time from symptom onset to surgery can exceed a year. How do referral pathways affect stage at treatment and recurrence risk? pubmed.ncbi.nlm.nih.gov/4177…

Presented today at #GU26 @ASCO: Results from SURE-02 - Neoadjuvant sacituzumab govitecan plus pembrolizumab, followed by adjuvant pembrolizumab, in patients with muscle-invasive bladder cancer: a single-arm, phase 2 study Read the full paper⬇️ thelancet.com/journals/lanon…

closing out our live surgery from @RoyalFreeNHS for #ERUS25 with a complex robotic radical nephrectomy made to look so easy by @Zondervan_AUMC… such a pleasure to learn from a huge thank you to the whole team @RoyalFreeNHS that made this congress a complete success 💪🏽💪🏽

Packed room for the 2nd day of #ERUS25. Central screen @AlbertoBreda1 making history again with >5000 miles telesurgery RAPN! @Uroweb

Brilliant demonstration of totally RNU by @RaviBarodUrol and @RoyalFreeNHS team at #ERUS25. Proud to be part of the best renal cancer referral center! @Uroweb

A great experience to perform a robotic retro partial nephrectomy during #ERUS2025 in London with @RaviBarodUrol’s amazing team including @BasileG_ at @RoyalFreeNHS. A challenging case and a challenging day made easier being surrounded by the right people.

congratulations @NNHarke and our excellent team @RoyalFreeNHS for beautifully demonstrating a complex robotic partial nephrectomy for @ERUSrobotics #ERUS25 … the audience were captivated 😎

Fantastic retro partial nephrectomy masterclass at @RoyalFreeNHS! Prof Mumtaz & @RaviBarodUrol delivered superb surgical demos with @benchallacombe showcasing SP robotic tech. Thanks to our amazing team, attendees & partners @Proximie @Fujifilm_UKI @JNJNews @Intuitive for support

Take-home messages of Dr. Basile's presentation "What's new in molecular imaging" regarding the future perspectives regarding the characterisation of equivocal renal masses. #EAU25

@BasileG_ outlining the latest updates on #imaging technologies available to better identify #renal masses, presenting the results of our study published in @EuropeanUrology. 🩻precise imaging can dramatically change patient’s management! #EAU25 @Uroweb

Join us for a Live Course on Robotic Retroperitoneal Partial Nephrectomy at the Royal Free in London. Opportunity to watch 2 live cases and interact with leading experts in the field. 6 CPD points approved by BAUS. Scan the QR code to view the programme.

Going to miss the Saturday hit list with the great team and the amazing @RaviBarodUrol. Always pleasure to have @ShoniwaAngeline ⭕️ 4 Robotic raical nephrectomy ⭕️Outstanding example of highly effective team work ⭕️ Highly challenging but highly satisfying.

Comprehensive review of UTUC surgical management chemoprophaxis and surveillance by @BasileG_ @SpiessPhilippe @GTumors @BandiniMd @UrogerliMD journals.lww.com/co-urology/…

Today in #PiS: This meta-analysis confirms that #ERBT and #cTURBT yield comparable early oncological outcomes, with ERBT being associated with fewer intraoperative adverse events. The enhanced histopathological accuracy obtained from ERBT enables better patient stratification, potentially leading to more effective subsequent care delivery. Tailoring the resection technique to patient and disease characteristics will likely improve patient outcomes. Read more 👇 pubmed.ncbi.nlm.nih.gov/3942…

Today in #PiS: Should we stop doing systematic biopsy when targeting an #MRI visible lesion? This systematic review and meta-analysis supports the recent recommendation from the @EAU Guidelines, though the addition of systematic #biopsy might still be useful for treatment planning. Click the link below 👇 pubmed.ncbi.nlm.nih.gov/3945…

Highlight of the day @57_UroPuigvert Bilateral simultaneous VEIL performed by @Dr_JMGaya @UROGavrilov. Resident @raultfe assisting and @FPuigvert former fellow @BasileG_ moderating the wonderful surgery A big start!! @AlbertoBreda1

Out in @JCO_ASCO our next piece of the neoadjuvant puzzle in muscle-invasive #bladdercancer. Taxanes could be another good choice of backbone chemo to combine with IO, overcoming the known limits of platinum. #NureCombo provided Nivo/ABX x4 > RC > adj Nivo x13. N=31. 22 pts (70.9%, 95%CI: 51.9-85.8%) achieved a ypT</=1N0-x response. In the ITT population, 10 pts (32.3%, 95% CI: 16.7-51.4) achieved an ypT0N0 response. By including those who underwent reTURBT, 12 pts (38.7%; 95%CI: 22-56) achieved an ypT0N0-x response. @CMercinelli @vale_tateo @Anto_cigliola @BrigidaMaiorano @GiorgioBre @FDeCobelli @gio_pasto_real @BasileG_ @UroMoschini @DanieleRaggi83 @Albert0Briganti @SanRaffaeleMI @MyUniSR @urotoday @Medscape @ASCO ascopubs.org/doi/10.1200/JCO…

Orthotopic Robot-assisted Kidney Transplantation: Surgical Technique and Preliminary Results by @FrancescVigues et al Full article: buff.ly/451RZAC @AngeloTerrito @agallioli @camilleberquin @BasileG_ @oscar_buisan @NicoDoumerc #UroSoMe #Medtwitter @SiMEuropeanUro

Simulation&proficiency-based progression #training programs: new #quality standard to gain surgical proficiency in #Urology. A shared pathway across disciplines to assess the impact of this novel training methodology on patient outcomes is needed. @BasileG_ in #PuigvertInScience

New frontiers with #robotic orthotopic #kidneytransplantion to expand the indications of #RAKT 🗣️ Today Dr. @AlbertoBreda1 in #PuigvertInScience Read the article 👇 bit.ly/3w1uHy4